野生动物健康市场、机会、成长动力、产业趋势分析与预测，2024-2032

Wildlife Health Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月30日 | 出版商:

Global Market Insights Inc. | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球野生动物健康市场价值为23 亿美元，预计2024 年至2032 年复合年增长率为8.9%。可以在动物和人类之间传播。城市化、森林砍伐和气候变迁加剧了人类与野生动物的互动，提高了全球对野生动物健康的认识。例如，2023 年 10 月，俄勒冈州立大学的研究人员根据美国农业部的一项协议，对约 1,600 份野生动物标本进行了 SARS-CoV-2 检测，以确定可以隐藏和传播该病毒的物种。该倡议强调了监测和管理野生动物健康以防止疾病传播的重要性。政府机构和卫生机构正在投资野生动物健康倡议，增加了对兽医服务、诊断工具和研究的需求。

整个野生动物健康产业根据物种、产品和服务、医疗器材、最终用户和地区进行分类。

市场将物种分为哺乳动物、鸟类、鱼类、爬虫类和两栖类。哺乳动物细分市场在 2023 年以 10 亿美元的收入引领市场，预计将以 8.8% 的复合年增长率保持其主导地位。哺乳动物在生态系统和人畜共通传染病传播中发挥着至关重要的作用，这使得它们成为野生动物健康研究的核心。它们复杂的生理机能和多样化的栖息地需要集中研究和监测，以管理和预防疾病爆发、保护生物多样性并确保公众健康。

市场将产品和服务分为药品、医疗器材和兽医服务。 2023年，药品领域占46.8%的市场份额，预计将继续保持主导地位。该部分包括药物、疫苗和医疗添加剂，对于管理和治疗各种野生动物物种的疾病至关重要。对有效治疗和预防措施的需求以及兽医学的创新推动了市场的成长。此外，人们对人畜共通传染病的认识不断提高，以及野生动物保护工作中对强有力的疾病管理的需求，进一步促进了製药领域的扩张。

2023年，美国占北美野生动物健康市场的9.213亿美元，预计将大幅成长。美国凭藉其丰富的资源、先进的研究能力以及美国鱼类和野生动物管理局和疾病预防控制中心等联邦机构的大量投资而引领市场。该国还受益于致力于野生动物福利的强大兽医机构网络。美国在监测、疾病管理和保育工作方面拥有强大的基础设施，使其成为应对野生动物健康挑战和推动市场发展的领导者。

产业生态系统分析
产业影响力
- 成长动力
  - 对人畜共通传染病的担忧日益增加
  - 野生动物保育意识和努力不断提高
  - 诊断和野生动物健康福利的进步。
  - 政府和非政府组织对动物保健的支持不断增加
  - 不断增加的研究措施和资金
- 产业陷阱与挑战
  - 严格的法规和复杂的法律框架
  - 治疗和护理费用高
  - 缺乏野生动物兽医
成长潜力分析
监管环境
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按物种，2021 - 2032 年

主要趋势
哺乳动物
鸟类
鱼
爬虫类
两栖类

第 6 章：市场估计与预测：按产品和服务划分，2021 - 2032 年

主要趋势
药品
- 药品
- 疫苗
- 医药添加物
医疗器材
- 诊断设备
- 手术器械
- 监控设备
- 耗材
- 其他医疗器材
兽医服务

第 7 章：市场估计与预测：按最终用户划分，2021 - 2032 年

主要趋势
野生动物復健中心
动物园和水族馆
野生动物保护区
其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Bimeda, Inc.
CJ Wildlife
Esaote SpA
Esco VacciXcell
Fagron
Hidrolab
Huvepharma
NexGen Pharmaceuticals
Nextech
Virbac
Telemetry solutions
Wildlife Computers

简介目录

Product Code: 11145

The Global Wildlife Health Market was valued at USD 2.3 billion in 2023 and is projected to grow at a CAGR of 8.9% from 2024 to 2032. This growth is driven by increased awareness of zoonotic diseases, which can spread between animals and humans. Urbanization, deforestation, and climate change have intensified human-wildlife interactions, raising global awareness of wildlife health. For instance, in October 2023, Oregon State University researchers, under a U.S. Department of Agriculture agreement, tested around 1,600 wild animal specimens for SARS-CoV-2 to identify species that can harbor and transmit the virus. This initiative highlights the importance of monitoring and managing wildlife health to prevent disease transmission. Government bodies and health agencies are investing in wildlife health initiatives, boosting demand for veterinary services, diagnostic tools, and research.

The overall wildlife health industry is classified based on the species, products and services, medical devices, end-user, and region.

The market categorizes species into mammals, birds, fish, reptiles, and amphibians. The mammals segment led the market in 2023 with USD 1 billion in revenue and is expected to maintain its dominance with a CAGR of 8.8%. Mammals play a crucial role in ecosystems and zoonotic disease transmission, making them central to wildlife health studies. Their complex physiology and diverse habitats necessitate focused research and monitoring to manage and prevent disease outbreaks, protect biodiversity, and ensure public health.

The market classifies products and services into pharmaceuticals, medical devices, and veterinary services. In 2023, the pharmaceuticals segment held a 46.8% market share and is expected to remain dominant. This segment includes drugs, vaccines, and medical additives, essential for managing and treating diseases across various wildlife species. The demand for effective treatments and preventive measures, along with innovations in veterinary medicine, drives the market's growth. Additionally, increasing awareness of zoonotic diseases and the need for robust disease management in wildlife conservation efforts further contribute to the expansion of the pharmaceuticals segment.

In 2023, the U.S. accounted for USD 921.3 million of the North American wildlife health market and is expected to grow significantly. The U.S. leads the market due to its extensive resources, advanced research capabilities, and substantial investments from federal agencies like the U.S. Fish and Wildlife Service and the CDC. The country also benefits from a robust network of veterinary institutions dedicated to wildlife welfare. The U.S.'s strong infrastructure for monitoring, disease management, and conservation efforts positions it as a leader in addressing wildlife health challenges and advancing the market.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing zoonotic disease concerns
  - 3.2.1.2 Rising awareness and efforts for wildlife conservation
  - 3.2.1.3 Advancements in diagnostics and wildlife health welfare.
  - 3.2.1.4 Rising government and NGO support for animal healthcare
  - 3.2.1.5 Growing research initiatives and funding
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Stringent regulations and complex legal frameworks
  - 3.2.2.2 High cost of treatment and care
  - 3.2.2.3 Lack of wildlife veterinarians
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Species, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Mammals
5.3 Birds
5.4 Fish
5.5 Reptiles
5.6 Amphibians

Chapter 6 Market Estimates and Forecast, By Products and Services, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Pharmaceuticals
- 6.2.1 Drugs
- 6.2.2 Vaccines
- 6.2.3 Medical additives
6.3 Medical devices
- 6.3.1 Diagnostic equipment
- 6.3.2 Surgical instruments
- 6.3.3 Monitoring devices
- 6.3.4 Consumables
- 6.3.5 Other medical devices
6.4 Veterinary services

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Wildlife rehabilitation centers
7.3 Zoos and aquariums
7.4 Wildlife sanctuaries
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa